FDA approves a new type of schizophrenia drug
Establishment Labs, FDA and Motiva
FDA Lifts Clinical Hold On BMF-219
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results